AI Solutions for Investment Decisions in Pharma

This document is a case study detailing the application of AI solutions developed by Intelligencia AI for investment decision-making in the pharmaceutical and financial sectors. It outlines several real-world use cases where the company collaborated with clients to enhance their return on investment (ROI) and make informed decisions. The first case discusses the creation of a portfolio of early-stage biotech companies with oncology pipelines, achieving a 60% return compared to lower returns from similar companies and benchmarks. The second case highlights a global pharmaceutical company's need for prioritizing oncology assets in the Chinese market, where AI-driven assessments resulted in a targeted list of 20 assets from over 1,000 in just eight weeks. The final case presents an external assessment of acquisition targets, revealing significant discrepancies between internal and AI-driven evaluations, leading to substantial financial savings by avoiding a failed investment. The document emphasizes the effectiveness of AI in enhancing decision-making processes in the pharmaceutical industry.